In 2019, operation Pangea took on a new form. This operation focused on information collection, analysis and communication. For this twelfth edition, that took place from June 2018 to June 2019, the FAMHP provided the necessary data. Pangea is coordinated by INTERPOL and is specifically designed to intercept illegal and counterfeit medicinal products and devices.http://www.medicaments-par-internet.be
Operation Pangea XII: FAMHP seizes 5,360 packages, containing almost 500,000 counterfeit or illegal products
18 to 24 November, 2019 is the international week of sensitization on prudent use of antibiotics. Not only in humans, but in animals too. Antibiotic use in veterinary medicine has fallen sharply in recent years, but the fight isn't over yet.
How can health authorities such as the Federal Agency for Medicines and Health Products (FAMHP), in cooperation with the FPS Public Health, Safety of the Food Chain and Environment (SPF Public Health), the National Institute for Illness and Invalidity Insurance (RIZIV) and the Federal Knowledge Centre for Health Care (KCE) involve patients more (pro)actively and put them in a more central position throughout the complete development cycle of innovative medications?
From January 2020 there is a new nomenclature applicable for manufacturers reporting an incident with a medical product to the FAMHP. The FAMHP advises manufacturers of medical devices to already change their internal codes to the new nomenclature codes.
During the Christmas holidays, the FAMHP will be closed from Wednesday 25 December 2019 until Wednesday 1 January 2020 included.
As of November 1, 2019, the duration of validity of a medical prescription will be a standard three months
The pharmacist can now only deliver medications up to three months after the prescription date, with the exception of when the prescriber indicates a date of delivery. For reimbursed medications, the reimbursement date is also three months from the date on which the prescriber issued the prescription.
New ESVAC report: antibiotics use falls again in animal breeding in Europe. Further efforts are necessary, in Belgium as well
The European Medicines Agency (EMA) published the ninth ESVAC report (European Surveillance of Veterinary Antimicrobial Consumption) about the sale of antibacterial agents for veterinary use in 2017.
Update - Unavailability and start or stop of commercialisation: no reporting possible between December 2 and 5, 2019
A new reporting system will be available on December 5, 2019. To avoid errors, reports may only be made through the current system until December 2, 2019.
From 1 November 2019, a new form will apply for requesting validation of Direct Healthcare Professional Communications (DHPCs).
Information session about PharmaStatus, the new application for reporting and consulting unavailability and start or stops of commercialisation
Via the new online application PharmaStatus, marketing authorization holders can notify the FAMHP of unavailability and start or stop of commercialization of a drug. Marketing authorization holders are invited to an information session on November 18, 2019.